[Prevalence of microtia and anotia at the maternity of the University of Chile Clinical Hospital].

BACKGROUND Microtia is a congenital defect characterized by disturbances in the size and form of the ear lobe. Anotia corresponds to the absence of the ear lobe. AIM To study the prevalence of microtia and anotia at the Maternity of the University of Chile Clinical Hospital. MATERIAL AND METHODS Analysis of the database of the Latin American Collaborative Study of Congenital Defects (ECLAMC). All newborns and stillborns with congenital defects are incorporated to this database. RESULTS The prevalence of microtia-anotia in the period 1982-2001 was 8.7 per 10,000 born alive. Chilean hospitals have an uniform prevalence of 5.2 per 10,000 born alive. Thirty seven percent presented as isolated malformations and the rest were associated to other defects. Eighty six percent of non isolated cases were part of a syndrome. Sixty eight percent were mild or moderate forms and the rest, severe forms. Two cases were stillborns and two newborns died before hospital discharge. CONCLUSIONS The prevalence of microtia in this hospital and in the rest of Chilean hospitals is significantly higher than in the rest of non Chilean hospitals participating in the ECLAMC, that is 4.1 per 10,000 born alive.

[1]  E. Castilla,et al.  ECLAMC: The Latin-American Collaborative Study of Congenital Malformations , 2004, Public Health Genomics.

[2]  M. Golabi,et al.  Oculoauriculovertebral abnormalities in children of diabetic mothers. , 2000, American journal of medical genetics.

[3]  G. Shaw,et al.  Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. , 1997, American journal of public health.

[4]  B. Källén,et al.  The epidemiology of anotia and microtia. , 1996, Journal of medical genetics.

[5]  G. Zampino,et al.  Epidemiology and genetics of microtia-anotia: a registry based study on over one million births. , 1995, Journal of medical genetics.

[6]  R W Smithells,et al.  Recognition of thalidomide defects. , 1992, Journal of medical genetics.

[7]  K. Ørstavik,et al.  Right‐sided microtia and conductive hearing loss with variable expressivity in three generations , 1990, Clinical genetics.

[8]  E. Castilla,et al.  Prevalence rates of microtia in South America. , 1986, International journal of epidemiology.

[9]  A. Wilk,et al.  Teratogen update: vitamin A congeners. , 1986, Teratology.

[10]  S. Takemori,et al.  Thalidomide anomalies of the ear. , 1976, Archives of otolaryngology.

[11]  D. Poswillo,et al.  The pathogenesis of the first and second branchial arch syndrome. , 1973, Oral surgery, oral medicine, and oral pathology.

[12]  J. Kucera Rate and type of congenital anomalies among offspring of diabetic women. , 1971, The Journal of reproductive medicine.

[13]  J. Śanchez-Corona,et al.  A distinct dominant form of microtia and conductive hearing loss. , 1982, Birth defects original article series.

[14]  Aase Jm,et al.  Microtia in New Mexico: evidence for multifactorial causation. , 1977 .